background image

Triple Negative Breast Cancer Clinical Trials

Find clinical trials for triple negative breast cancer. Search for triple negative breast cancer clinical trials in different cities and states across the United States.

Filter
1

ZN-c3, Carboplatin, Pembrolizumab

Recruiting
PHASE1
PHASE2

Sponsor:

Filipa Lynce, MD

Location:

Boston MA

Code:

NCT06351332

Conditions

Breast Cancer

Breast Cancer Female

Triple Negative Breast Cancer

Hormone Receptor Negative Malignant Tumor Breast Triple

HER2-negative Breast Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Azenosertib

Carboplatin

Pembrolizumab

BAL0891

Recruiting
PHASE1

Sponsor:

SillaJen, Inc.

Location:

Coral Gables FL, Bronx NY, Portland OR

Code:

NCT05768932

Conditions

Advanced Solid Tumor

TNBC - Triple-Negative Breast Cancer

Gastric Cancer

Leukemia Acute Myeloid Leukemia (AML)

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

BAL0891

Carboplatin

Paclitaxel

SBRT

Recruiting
PHASE2

Sponsor:

Memorial Sloan Kettering Cancer Center

Location:

Hartford CT, Norwalk CT, Miami FL, Basking Ridge NJshow 7 more

Code:

NCT03808337

Conditions

Triple Negative Breast Cancer

Non Small Cell Lung Cancer

Metastatic Breast Cancer

Metastatic Non-Small Cell Lung Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Stereotactic Body Radiotherapy/SBRT

Systemic Therapy/Standard of Care

Dendritic Cell Vaccine

Recruiting
PHASE1

Sponsor:

H. Lee Moffitt Cancer Center and Research Institute

Location:

Tampa FL

Code:

NCT05809752

Conditions

Leptomeningeal Disease

Triple Negative Breast Cancer

HER2-positive Breast Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Dendritic Cell Vaccine

PBA-0405

Recruiting
EARLY_PHASE1

Sponsor:

Pure Biologics S.A.

Location:

Shreveport LA, Portland OR, Philadelphia PA, Charleston SC

Code:

NCT06273852

Conditions

Head and Neck Squamous Cell Carcinoma

Soft Tissue Sarcoma Adult

Triple Negative Breast Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

PBA-0405

Interested in new trials?

Get alerts for new trials in your area by subscribing now

By submitting, you consent to the use of your personal details, including contact information and location, to respond to your request for information related to clinical trials, as outlined in the Privacy Policy. If at any time you want to discontinue receiving alerts, please click the Unsubscribe link in the email received.

TM & Capecitabine

Recruiting
PHASE1
PHASE2

Sponsor:

Dartmouth-Hitchcock Medical Center

Location:

Lebanon NH

Code:

NCT06134375

Conditions

Triple Negative Breast Cancer

Residual Disease

Eligibility Criteria

Sex: All

Age: 18 - 70

Healthy Volunteers: Not accepted

Interventions

Tetrathiomolybdate

Capecitabine

Pembrolizumab

LY4101174

Recruiting
PHASE1

Sponsor:

Eli Lilly and Company

Location:

Orlando FL, Atlanta GA, Boston MA, Saint Louis MOshow 3 more

Code:

NCT06238479

Conditions

Metastatic Solid Tumor

Recurrent Solid Tumor

Advanced Solid Tumor

Urinary Bladder Neoplasm

Triple Negative Breast Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

LY4101174

AO-252

Recruiting
PHASE1

Sponsor:

A2A Pharmaceuticals Inc.

Location:

Detroit MI, Oklahoma City OK, Dallas TX, Houston TXshow 1 more

Code:

NCT06136884

Conditions

Triple Negative Breast Cancer

High Grade Serous Ovarian Cancer

Endometrial Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

AO-252

BG-68501

Recruiting
PHASE1

Sponsor:

BeiGene

Location:

Newport Beach CA, Lake Mary FL, Saint Louis MO, East Brunswick NJshow 2 more

Code:

NCT06257264

Conditions

Breast Cancer

Small Cell Lung Cancer

Ovarian Cancer

Gastric Cancer

Hormone-receptor-positive Breast Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

BG-68501

Fulvestrant

BGB-43395

CTX-8371

Recruiting
PHASE1

Sponsor:

Compass Therapeutics

Location:

Margate FL, Orlando FL, Sarasota FL, Boston MAshow 2 more

Code:

NCT06150664

Conditions

Non Small Cell Lung Cancer

Triple Negative Breast Cancer

Hodgkin Lymphoma

Head and Neck Squamous Cell Carcinoma

Malignant Melanoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

CTX-8371